Clin2
NCT06116396Likely a fitRecruiting

Liquid biopsy for newly diagnosed urinary cancers

Urothelial Carcinoma

Part of Cancer clinical trials.

This trial is testing a simple, non-invasive blood test to find genetic markers for urinary tract cancers. It's for people newly diagnosed who haven't started treatment yet.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
450 people
Ages
40 years and older
Study type
Observational

Who can take part

  • You must have been diagnosed with a cancer of the urinary tract lining (like bladder or ureter cancer).
  • You should not have received any treatment for this cancer before joining the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06310759Recruiting
Testing urine DNA for bladder cancer detection

This trial looks at whether a large urine sample can detect bladder cancer DNA. It may help diagnose cancer without needing a cystoscopy. You can join if you are about to have a cystoscopy to check for bladder cancer.

Chicago, Illinois
NCT06469229Not yet recruiting
Urine test for bladder cancer in people with blood in urine

This study tests a new urine test that looks for DNA changes to find bladder or urinary tract cancer in people who have blood in their urine. The goal is to see if this simple test can detect cancer early.

Shanghai, Shanghai Municipality
NCT06218433Recruiting
Bladder cancer screening for Lynch syndrome with a urine test

This study is testing a urine test to see if it can find bladder cancer early in people with Lynch syndrome. If you have Lynch syndrome and are between 50 and 75, this screening could help catch cancer before it causes symptoms.

Vancouver
NCT05889195Recruiting
Urine test to sort bladder cancer risk after blood in urine

This study tests whether a special urine testing approach can better identify and sort risk in people (especially veterans) who were referred to urology for blood in the urine. It may help doctors decide who needs more urgent follow-up and which next steps to take.

Murrieta, California
NCT06863844Recruiting
DNA markers for predicting outcomes in urothelial cancer

This trial studies DNA markers in tumor tissue or blood samples to see if they can predict how well treatments work or how the cancer behaves. It may help doctors better understand and manage urothelial cancer in the future.

Bologna
NCT06145139Enrolling by invitation
Liquid biopsy for kidney cancer: tracking tumor DNA after surgery

This study looks at whether a simple blood test can detect tiny bits of kidney cancer DNA after surgery. If successful, it could help doctors spot a return of cancer earlier than scans alone.

Aarhus N

Hear when a new Urothelial Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.